Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00138827Phase 4Completed
Phase 4, randomised trial of sodium monofluorophosphate in xerostomia and mucositis (2 arms), sponsored by St George Hospital. Primary endpoints: Oral comfort, Mucositis and 2 more. Started Nov 1999; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00138827.